NERV · CIK 0001598646 · FY2025 live · 2025-12-31
Minerva Neurosciences, Inc.
View as
Model
Classic Z
FY2025
−9.72
Zone
Distress
Prior
—
Market DD
—
1y PD
—
Meridian Rank
8.18
0–100 · Classic Z tape · not a PD
Book standing
9
Year change
—
Market PD
—
O-score
6
Events on this name
Same published rows as Today. Not a live recompute.
MARKET PD UNAVAILABLE
watch · 41
- mertonPd: — → —
−9.72
Z″ −19.18
Score −9.72 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.821.2 × = 0.99X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−7.031.4 × = −9.84X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−0.153.3 × = −0.51X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
−0.600.6 × = −0.36X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.001 × = 0.00
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
Minerva Neurosciences, Inc. is on classic Z at −9.72 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 16th percentile in Healthcare.
- ENTXDistressEntera Bio Ltd.−9.65
- CRDFDistressCardiff Oncology, Inc.−9.83
- VVOSDistressVivos Therapeutics, Inc.−9.58
- HRTXDistressHERON THERAPEUTICS, INC. /DE/−9.94
- MANEDistressVeradermics, Inc−9.50
- ATYRDistressaTYR PHARMA INC−9.45
- STRODistressSUTRO BIOPHARMA, INC.−10.03
- QNCXDistressQuince Therapeutics, Inc.−9.37
KPI widgets
Current assets
$83M
Total assets
$98M
Current liabilities
$2M
Total liabilities
$234M
Working capital
$81M
Retained earnings
−$689M
EBIT
−$15M
Total sales
$0
Book equity
−$141M
Accession 0001193125-26-101117. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 13 Sept 2026.